Calton & Associates, Inc. Eli Lilly & CO Transaction History

Calton & Associates, Inc.

$204 Million
Q1 2024

A detailed history of Calton & Associates, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Calton & Associates, Inc. holds 1,031 shares of LLY stock, worth $934,818. This represents 0.39% of its overall portfolio holdings.

Number of Shares

1,031

Previous 1,292 20.2%

Holding current value

$934,818

Previous $753,000 6.51%

% of portfolio

0.39%

Previous 0.3%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 16, 2024	SELL	$592.2 - $792.28 $154,564 - $206,785	-261 Reduced 20.2%	1,031 $802,000
Q4 2023 Feb 07, 2024	BUY	$525.19 - $619.13 $678,545 - $799,915	1,292 New	1,292 $753,000
Q2 2023 Jul 24, 2023	BUY	$350.74 - $468.98 $45,946 - $61,436	131 Added 11.02%	1,320 $619,000
Q1 2023 Apr 19, 2023	SELL	$310.63 - $364.82 $243,223 - $285,654	-783 Reduced 39.71%	1,189 $408,000
Q4 2022 Jan 18, 2023	BUY	$321.55 - $374.67 $67,203 - $78,306	209 Added 11.85%	1,972 $0

Q2 2022 Jul 12, 2022	SELL	$278.73 - $327.27 $71,354 - $83,781	-256 Reduced 12.68%	1,763 $571,000
Q1 2022 Apr 12, 2022	SELL	$234.69 - $291.66 $18,305 - $22,749	-78 Reduced 3.72%	2,019 $578,000
Q4 2021 Jan 13, 2022	SELL	$224.85 - $279.04 $86,792 - $107,709	-386 Reduced 15.55%	2,097 $579,000
Q3 2021 Nov 05, 2021	SELL	$221.6 - $272.71 $45,649 - $56,178	-206 Reduced 7.66%	2,483 $573,000
Q2 2021 Aug 11, 2021	BUY	$180.55 - $233.54 $180 - $233	1 Added 0.04%	2,689 $618,000
Q1 2021 May 03, 2021	SELL	$164.32 - $212.72 $63,427 - $82,109	-386 Reduced 12.56%	2,688 $502,000
Q4 2020 Jan 25, 2021	SELL	$130.46 - $172.63 $9,132 - $12,084	-70 Reduced 2.23%	3,074 $519,000
Q3 2020 Oct 30, 2020	BUY	$146.22 - $169.13 $25,003 - $28,921	171 Added 5.75%	3,144 $465,000
Q2 2020 Aug 10, 2020	SELL	$136.42 - $164.18 $29,057 - $34,970	-213 Reduced 6.69%	2,973 $488,000
Q1 2020 Apr 30, 2020	BUY	$119.05 - $147.35 $61,429 - $76,032	516 Added 19.33%	3,186 $442,000
Q4 2019 Feb 03, 2020	BUY	$106.92 - $132.43 $53,994 - $66,877	505 Added 23.33%	2,670 $351,000
Q3 2019 Nov 07, 2019	BUY	$106.79 - $116.16 $27,978 - $30,433	262 Added 13.77%	2,165 $242,000
Q2 2019 Jul 09, 2019	SELL	$110.79 - $129.32 $427,649 - $499,175	-3,860 Reduced 66.98%	1,903 $211,000
Q1 2019 Apr 25, 2019	BUY	$111.31 - $131.02 $20,592 - $24,238	185 Added 3.32%	5,763 $748,000
Q4 2018 Feb 11, 2019	BUY	$105.9 - $118.64 $97,428 - $109,148	920 Added 19.75%	5,578 $646,000
Q3 2018 Oct 24, 2018	BUY	$85.86 - $107.31 $204,260 - $255,290	2,379 Added 104.39%	4,658 $500,000
Q2 2018 Aug 10, 2018	BUY	$75.7 - $86.88 $172,520 - $197,999	2,279 New	2,279 $233,000
Q1 2018 Apr 17, 2018	SELL	$74.21 - $87.6 $209,123 - $246,856	-2,818 Closed	0 $0
Q4 2017 Feb 05, 2018	BUY	$81.94 - $87.89 $230,906 - $247,674	2,818	2,818 $237,000

Others Institutions Holding LLY

# of Institutions

3,721

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $862B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Calton & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Calton & Associates, Inc. with notifications on news.

Account

Calton & Associates, Inc. Eli Lilly & CO Transaction History